相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling
John W. Calvert et al.
DIABETES (2008)
Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review
Dean T. Eurich et al.
BMJ-BRITISH MEDICAL JOURNAL (2007)
Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy
Hong-Liang Li et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway
Ichiro Shiojima et al.
GENES & DEVELOPMENT (2006)
Statins activate AMP-activated protein kinase in vitro and in vivo
Wei Sun et al.
CIRCULATION (2006)
Metformin influences cardiomyocyte cell death by pathways that are dependent and independent of caspase-3
D. An et al.
DIABETOLOGIA (2006)
AMP-activated protein kinase is involved in endothelial NO synthase activation in response to shear stress
Yingjia Zhang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase
BJ Davis et al.
DIABETES (2006)
AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress
K Terai et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2 dependent mechanisms
R Shibata et al.
NATURE MEDICINE (2005)
Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism
YL Liao et al.
CARDIOVASCULAR RESEARCH (2005)
Exogenous nitric oxide reduces glucose transporters translocation and lactate production in ischemic myocardium in vivo
BA Lei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Blood glucose and heart failure in nondiabetic patients
C Nielson et al.
DIABETES CARE (2005)
Celiprolol, a vasodilatory β-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice
YL Liao et al.
CIRCULATION (2004)
Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte
AYM Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Adiponectin-mediated modulation of hypertrophic signals in the heart
R Shibata et al.
NATURE MEDICINE (2004)
Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo -: Role of mitochondrial reactive nitrogen species (Publication with Expression of Concern. See vol. 294, pg. 10024, 2019) (Withdrawn Publication. See vol. 294, pg. 13525, 2019)
MH Zou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
TSC2 mediates cellular energy response to control cell growth and survival
K Inoki et al.
CELL (2003)
Myocardial ischemia and increased heart work modulate the phosphorylation state of eukaryotic elongation factor-2
S Horman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-α in pacing-induced heart failure
JC Osorio et al.
CIRCULATION (2002)
Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy
VG Dávila-Román et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Nitric oxide: an emerging role in cardioprotection?
RD Rakhit et al.
HEART (2001)
Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser1179
M Montagnani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
